1 reports of this reaction
2.3% of all HISTAMINE DIHYDROCHLORIDE reports
#7 most reported adverse reaction
ANKYLOSING SPONDYLITIS is the #7 most commonly reported adverse reaction for HISTAMINE DIHYDROCHLORIDE, manufactured by ALPHA NUTRITION, LLC. There are 1 FDA adverse event reports linking HISTAMINE DIHYDROCHLORIDE to ANKYLOSING SPONDYLITIS. This represents approximately 2.3% of all 44 adverse event reports for this drug.
Patients taking HISTAMINE DIHYDROCHLORIDE who experience ankylosing spondylitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANKYLOSING SPONDYLITIS is a less commonly reported adverse event for HISTAMINE DIHYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to ankylosing spondylitis, the following adverse reactions have been reported for HISTAMINE DIHYDROCHLORIDE:
ANKYLOSING SPONDYLITIS has been reported as an adverse event in 1 FDA reports for HISTAMINE DIHYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANKYLOSING SPONDYLITIS accounts for approximately 2.3% of all adverse event reports for HISTAMINE DIHYDROCHLORIDE, making it a notable side effect.
If you experience ankylosing spondylitis while taking HISTAMINE DIHYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.